Alexander Sleigh
Angel Investor @ Maven Capital Partners
London, United Kingdom
Alexander Sleigh is a seed investor at Maven Capital Partners in London focused on Analytics and Data Visualization. Alexander is the commercial manager for Angel Capital Group which includes the LBA network.Alexander plays a key role in the sourcing and assessment of investment opportunities. He then works closely with the selected entrepreneurs in preparation for each Company Presentation Event, and beyond as they look to secure funding. Furtherresponsibilities include management of investor relations, communications, marketing, events and administration for the whole of ACG.Alexander holds a MA (Hons) in Economics and Modern History from the University of St. Andrews, and a Masters in Management from the Vlerick Leuven Ghent Management School. Alexander joined ACG from Jendens Securities where he worked as a junior TMT analyst.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Alexander Sleigh invests in
Stages Alexander Sleigh invests in
Countries Alexander Sleigh invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Analytics 2 (67%)
- Data Visualization 2 (67%)
- Artificial Intelligence 2 (67%)
- Health Care 1 (33%)
- Data Integration 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Our daily mission is the transformation of data deployment through our unique data as a service (DaaS) solution. | $2.9M / Seed / Oct 02, 2024 | ||
| RwHealth is a London-based Venture Capitalist (VC) backed healthcare AI and Machine learning predictive data and analytics company. We leverage data from public sector organizations and private companies both nationally and globally. We have been providing our customers with solutions that improve efficiencies, opportunities, outcomes and growtheir revenues/income. Over the years we have worked with a number of companies helping them to drive cost improvements, form new strategic partnerships, improving health outcomes, and more.Our operational patient flow, predictive analytics and insights platform is an intrinsic part of how hospitals and healthcare providers run their organisations on a daily basis and isn’t an optional add-on but rather a fundamental patient flow tool set.We have successfully deployed our platform into private and public hospitals and healthcare systems and have already delivered over £31m in combined efficiency opportunities for our customers. D&D operates in the UK, US and Australia with an ongoing focus on growth. | $1.7M / Series A / Jun 13, 2024 | ||
| RwHealth is a London-based Venture Capitalist (VC) backed healthcare AI and Machine learning predictive data and analytics company. We leverage data from public sector organizations and private companies both nationally and globally. We have been providing our customers with solutions that improve efficiencies, opportunities, outcomes and growtheir revenues/income. Over the years we have worked with a number of companies helping them to drive cost improvements, form new strategic partnerships, improving health outcomes, and more.Our operational patient flow, predictive analytics and insights platform is an intrinsic part of how hospitals and healthcare providers run their organisations on a daily basis and isn’t an optional add-on but rather a fundamental patient flow tool set.We have successfully deployed our platform into private and public hospitals and healthcare systems and have already delivered over £31m in combined efficiency opportunities for our customers. D&D operates in the UK, US and Australia with an ongoing focus on growth. | $8.5M / Series A / Nov 01, 2021 |
Co-Investors
About Maven Capital Partners
Maven Capital Partners was formed in 2009 following a management buyout of the private equity business of Aberdeen Asset Management PLC. Maven is now one of the UK’s leading private equity firms in the lower-mid market, specialising in investments in high-growth British companies. With a focus on innovation and value creation, Maven partners withvisionary entrepreneurs to build market-leading businesses, supporting a range of transaction types, including management buyouts, growth capital, buy-and-build projects, equity value release, and pre-IPO financing.Since 2009, Maven has also helped institutional, private client, and retail investors access private markets, including tax-efficient Venture Capital Trusts, deal-by-deal co-investment in private equity and property, and institutional buyout funds.
Maven Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andy Round
Investment Director
|
|||
Dave Furlong
Investment Director
|
|||
Gavin Bell
Investment Manager
|
|||
James Darlington
Investment Manager
|
|||
Jock Gardiner
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alexander Sleigh invest in?
Alexander Sleigh invests primarily in Analytics, Data Visualization and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alexander Sleigh?
Public channels for Alexander Sleigh include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alexander Sleigh last invest?
The most recent investment recorded for Alexander Sleigh closed in Oct 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
